Zimmer (ZMH) PT Raised at Needham & Company on Biomet Deal
Tweet Send to a Friend
Needham & Company analyst Mike Matson reiterated a Buy rating and raised his price target on Zimmer Holdings (NYSE: ZMH) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE